SCHEMBL2742906

SCHEMBL2742906

O=S(=O)(O)c1cc(Cl)ccc1-c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 2/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.41
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
SRD5A2 P31213 1/20 0.40
AHR P35869 1/20 0.38
HSP90AA1 P07900 1/20 0.37
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
IKBKB O14920 2/20 0.36
CHUK O15111 2/20 0.36
ACLY P53396 1/20 0.36
MCL1 Q07820 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6562906 0.89 ACLY (0.47) S100A4PTGDR2PTGS2PTGS1HSP90AA1
SCHEMBL196568 0.88 S100A4 (0.48) S100A4HSP90AA1MCL1ALDH1A1ALOX15
Hydrochloric Acid SCHEMBL2766272 0.87 ACLY (0.46) S100A4PTGDR2PTGS2PTGS1HSP90AA1
SCHEMBL3699050 0.86 S100A4 (0.46) S100A4HSP90AA1MCL1ALDH1A1ALOX15
SCHEMBL3695968 0.86 S100A4 (0.46) S100A4HSP90AA1MCL1ALDH1A1ALOX15
SCHEMBL3696775 0.86 S100A4 (0.46) S100A4HSP90AA1MCL1ALDH1A1ALOX15
SCHEMBL4301050 0.86 S100A4 (0.46) S100A4HSP90AA1MCL1ALDH1A1ALOX15
SCHEMBL7173896 0.85 S100A4 (0.42) S100A4PTGDR2PTGS2PTGS1SRD5A2
SCHEMBL29094192 0.84 S100A4 (0.45) S100A4PTGDR2PTGS2PTGS1SRD5A2
SCHEMBL8178016 0.81 PTGS2 (0.53) PTGS2PTGS1HSP90AA1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079830-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-14 US disclosed
US-20120322973-A1 POLYARYLENE POLYMERS AND PROCESSES FOR PREPARING E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-20 US disclosed
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-17 US disclosed
US-20120004387-A1 POLYARYLENE POLYMERS AND PROCESSES FOR PREPARING E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004387-A1 POLYARYLENE POLYMERS AND PROCESSES FOR PREPARING PCBP1, PARG, PARN S100A4 4405/4885PTGDR2 2955/4885PTGS2 2342/4885
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND AKR7A2, AOC2, CBR1 S100A4 4768/4885PTGDR2 2125/4885PTGS2 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.